Back

The role of T1 mapping and Extracellular Volume (ECV) in predicting cardiac reverse remodelling and response to Heart Failure with reduced Ejection Fraction (HFrEF) therapy

11 May 2023 (09:30 - 10:15)
Organised by:
Congress Presentation Part of: Heart Failure 2 Extracellular Volume EACVI Premium Access EACVI 2023

About the speaker

Photo
Doctor Alice Zheng

Portsmouth Hospitals NHS Trust, Portsmouth (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
The impact of BMI on myocardial work and left atrial strain in young overweight patients with preserved left ventricular ejection fraction
Doctor G. Trimarchi (Pisa, IT)
Abstract Slides
Presentation thumbnail
Symplified pulmonary ultrasound in heart failure patients with preserved systolic function
Professor M. Tsverava (Tbilisi, GE)
Abstract Slides
Presentation thumbnail
Baseline native T1 values are associated with adverse outcome in a newly diagnosed, hospitalised heart failure patient population
Doctor A. Zheng (Portsmouth, GB)
Abstract Slides
Presentation thumbnail
Acute effects of interruption of cardiac resynchronization therapy on left ventricular morpho-functional parameters as assessed by cardiac magnetic resonance
Doctor C. Basile (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Sex-specific impairment of cardiac functional reserve in HFpEF: insights from the HFpEF-Stress trial
Mr A. Schulz (Boston, US)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure 2

The Event

Event poster

EACVI 2023

11 May 2023 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Quantification of extracellular volume with cardiac computed tomography in patients with left ventricle dysfunction
thumbnail
Congress Presentation
Extra-cellular volume fraction analysis on cardiac CT is useful for predicting the prognosis of hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Comparative assessment of CMR-determined extracellular volume metrics in predicting adverse outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources